Headlands Technologies’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.8K Sell
11,547
-10,428
-47% -$45.1K 0.01% 675
2026
Q1
$85K Sell
21,975
-4,496
-17% -$18.4K 0.01% 672
2025
Q4
$111K Sell
26,471
-13,237
-33% -$51.2K 0.01% 625
2025
Q3
$131K Buy
39,708
+15,994
+67% +$45.2K 0.01% 565
2025
Q2
$33.7K Sell
23,714
-34,659
-59% -$49.3K ﹤0.01% 849
2025
Q1
$87K Buy
+58,373
New +$91.9K 0.01% 609
2023
Q3
Sell
-13,664
Closed -$15.7K 1136
2023
Q2
$15.7K Buy
+13,664
New +$16.1K 0.01% 582

Other funds holding PGEN

Headlands Technologies's PGEN Position: Q2 2026 in Review

Headlands Technologies reduced its Precigen (PGEN) stake by 47% in Q2 2026, selling an estimated $45.1K and leaving 11,547 shares worth $65.8K. The position accounts for 0.01% of the portfolio, ranked #675.

Headlands Technologies first reported a position in PGEN in Q2 2023 and has held it in 7 quarters since. The position peaked at $131K in Q3 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Headlands Technologies held 11,547 shares of Precigen worth $65.8K as of Q2 2026.
  • Headlands Technologies sold 10,428 Precigen shares in Q2 2026, an estimated $45.1K.
  • Precigen made up 0.01% of Headlands Technologies's portfolio in Q2 2026, its #675 holding.
  • Headlands Technologies first reported a position in Precigen in Q2 2023 and has held it in 7 quarters since.
  • Headlands Technologies's Precigen position peaked at $131K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.